We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$245M
AUM Growth
-$26.3M
Cap. Flow
-$19.2M
Cap. Flow %
-7.82%
Top 10 Hldgs %
63.13%
Holding
62
New
10
Increased
13
Reduced
23
Closed
14

Top Buys

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$19.7M
2
GSIT icon
GSI Technology
GSIT
+$8.68M
3
ANVS icon
Annovis Bio
ANVS
+$5.93M
4
CLNN icon
Clene
CLNN
+$5.8M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$5.09M

Top Sells

Rank Stock Value
1
ADTN icon
Adtran
ADTN
+$17.1M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$9.22M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$8.82M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$6.79M
5
APPS icon
Digital Turbine
APPS
+$5.49M

Sector Composition

Rank Sector Weight
1 Technology 47.43%
2 Healthcare 44.85%
3 Industrials 3.37%
4 Consumer Staples 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRB
26
Spruce Biosciences
SPRB
$127M
$2.39M 0.97%
14,813
+93
+0.6% +$15.5K
COYA icon
27
Coya Therapeutics
COYA
$107M
$2.39M 0.97%
586,872
+26,872
+5% +$125K
ADVM
28
DELISTED
Adverum Biotechnologies
ADVM
$2.36M 0.96%
148,356
+28,356
+24% +$298K
CAMP
29
DELISTED
CalAmp Corp.
CAMP
$2.18M 0.89%
89,285
+4,179
+5% +$203K
MDNA
30
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$2.09M 0.85%
4,339,983
-7,000
-0.2% -$4.33K
IPWR icon
31
Ideal Power
IPWR
$67.2M
$1.85M 0.75%
156,361
-56,707
-27% -$591K
APPS icon
32
Digital Turbine
APPS
$1.15B
$1.59M 0.65%
171,680
-498,365
-74% -$5.49M
CLRB icon
33
Cellectar Biosciences
CLRB
$20.5M
$1.59M 0.65%
27,107
-3,956
-13% -$190K
SLNO
34
DELISTED
Soleno Therapeutics
SLNO
$1.56M 0.64%
364,306
-58,183
-14% -$250K
BCLI
35
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.46M 0.6%
47,216
-50,057
-51% -$2.07M
FKWL icon
36
Franklin Wireless
FKWL
$26.8M
$1.45M 0.59%
390,000
– –
DFSC
37
DEFSEC Technologies
DFSC
$3.68M
$1.28M 0.52%
1,887
-18
-0.9% -$11K
OSA
38
DELISTED
ProSomnus, Inc. Common Stock
OSA
$1.19M 0.48%
386,433
-4,207
-1% -$20.2K
APRE icon
39
Aprea Therapeutics
APRE
$7.42M
$1.1M 0.45%
349,300
+4,300
+1% +$16K
MTLS
40
Materialise
MTLS
$388M
$1.08M 0.44%
+124,912
New +$1.08M
MYO icon
41
Myomo
MYO
$41.7M
$829K 0.34%
2,000,000
– –
TFFP
42
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$731K 0.3%
62,221
-7,344
-11% -$106K
CGRN
43
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$725K 0.3%
603,753
-10,150
-2% -$12.4K
RVLP
44
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$625K 0.26%
1,116,653
-139,740
-11% -$123K
TPST icon
45
Tempest Therapeutics
TPST
$14.2M
$516K 0.21%
+31,250
New +$786K
VCNX
46
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$472K 0.19%
6,441
+1,909
+42% +$159K
DFSCW
47
CALL
DEFSEC Technologies Warrant
DFSCW
$270K 0.11%
+599,000
New +$260K
SVREW
48
CALL
SaverOne 2014 Ltd Warrant
SVREW
$115K 0.05%
+568,694
New +$113K
ADTN icon
49
Adtran
ADTN
$710M
– –
-1,079,919
Closed -$17.1M
BCDA icon
50
BioCardia
BCDA
$13.5M
– –
-33,943
Closed -$994K
1
2
3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $737M AUM 17.98% 1-Year Est. Return

AIGH Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, AIGH Capital Management held 62 positions worth $245M, down 9.7% from $271M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

AIGH Capital Management withdrew a net $19.2M in Q2 2023, closing 14 positions and reducing 23 holdings. Its most notable exit was Adtran, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIGH Capital Management opened a new position in Microchip Technology worth $22.4M.

  • AIGH Capital Management's largest Q2 2023 buy was Microchip Technology: 250,000 shares worth $22.4M.
  • AIGH Capital Management added most to Apyx Medical in Q2 2023, an estimated $3.76M increase.
  • AIGH Capital Management's biggest Q2 2023 reduction was Digital Turbine, cutting an estimated $5.49M.
  • AIGH Capital Management fully exited Adtran in Q2 2023, selling an estimated $17.1M.
  • AIGH Capital Management's ten largest holdings make up 63% of its $245M portfolio in Q2 2023.
  • AIGH Capital Management opened 10 new positions and closed 14 in Q2 2023.
  • AIGH Capital Management's portfolio value fell 9.7% quarter-over-quarter to $245M.

Based on AIGH Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.